AU4841799A - Methods and pharmaceutical formulations for preventing and treating motion sickness - Google Patents

Methods and pharmaceutical formulations for preventing and treating motion sickness

Info

Publication number
AU4841799A
AU4841799A AU48417/99A AU4841799A AU4841799A AU 4841799 A AU4841799 A AU 4841799A AU 48417/99 A AU48417/99 A AU 48417/99A AU 4841799 A AU4841799 A AU 4841799A AU 4841799 A AU4841799 A AU 4841799A
Authority
AU
Australia
Prior art keywords
preventing
methods
pharmaceutical formulations
motion sickness
treating motion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU48417/99A
Inventor
Vincent D. Romeo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Marina Biotech Inc
Original Assignee
Marina Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US9111498P priority Critical
Priority to US60091114 priority
Application filed by Marina Biotech Inc filed Critical Marina Biotech Inc
Priority to PCT/US1999/014657 priority patent/WO2000000193A1/en
Publication of AU4841799A publication Critical patent/AU4841799A/en
Application status is Abandoned legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
AU48417/99A 1998-06-29 1999-06-29 Methods and pharmaceutical formulations for preventing and treating motion sickness Abandoned AU4841799A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US9111498P true 1998-06-29 1998-06-29
US60091114 1998-06-29
PCT/US1999/014657 WO2000000193A1 (en) 1998-06-29 1999-06-29 Methods and pharmaceutical formulations for preventing and treating motion sickness

Publications (1)

Publication Number Publication Date
AU4841799A true AU4841799A (en) 2000-01-17

Family

ID=22226169

Family Applications (1)

Application Number Title Priority Date Filing Date
AU48417/99A Abandoned AU4841799A (en) 1998-06-29 1999-06-29 Methods and pharmaceutical formulations for preventing and treating motion sickness

Country Status (2)

Country Link
AU (1) AU4841799A (en)
WO (1) WO2000000193A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040265238A1 (en) * 2003-06-27 2004-12-30 Imtiaz Chaudry Inhalable formulations for treating pulmonary hypertension and methods of using same
US9138228B2 (en) 2004-08-11 2015-09-22 Emory University Vascular conduit device and system for implanting
US7846123B2 (en) 2007-04-24 2010-12-07 Emory University Conduit device and system for implanting a conduit device in a tissue wall
AU2012211082B2 (en) 2011-01-28 2015-11-05 Apica Cardiovascular Limited Systems for sealing a tissue wall puncture
CA2826413A1 (en) 2011-02-01 2012-08-09 Georgia Tech Research Corporation Systems for implanting and using a conduit within a tissue wall
EP2948104B1 (en) 2013-01-25 2019-07-24 Apica Cardiovascular Limited Systems for percutaneous access, stabilization and closure of organs
US10485909B2 (en) 2014-10-31 2019-11-26 Thoratec Corporation Apical connectors and instruments for use in a heart wall

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4749700A (en) * 1984-10-23 1988-06-07 Nastech Pharmaceutical Co, Inc. Novel methods of administering antihistamines, antinausea and antiemetic pharmaceutical agents and novel dosage forms containing same

Also Published As

Publication number Publication date
WO2000000193A1 (en) 2000-01-06

Similar Documents

Publication Publication Date Title
AP1611A (en) Systems and methods for aerosolizing pharmaceutical formulations
GB2330531B (en) Pharmaceutical formulation for treating liver disorders
TW575423B (en) Pharmaceutical composition for the treatment of pain
EP1001813B8 (en) Pharmaceutical formulations containing voriconazole
EG23826A (en) Pharmaceutical formulations
AU777410C (en) Preserved pharmaceutical formulations
GB2323531B (en) Therapeutic formulations
IL109639A (en) High dose pharmaceutical formulations and manufacturing methods therefor
AU4217499A (en) Composition having therapeutic and/or nutritionally active substituent
AU6521498A (en) Suture retaining member for use in medical treatment
HU0103406A3 (en) 1h-imidazopyridine derivatives and pharmaceutical compositions thereof
AU4689796A (en) Formulations and methods for reducing skin irritation
AU4528596A (en) Formulations and methods for reducing skin irritation
AU2300699A (en) Amidino derivatives and drugs containing the same as the active ingredient
EP0643963A3 (en) Bioerodible device for administering active ingredients.
AU4205100A (en) Methods and compositions for the treatment of pancreatitis
AU2187992A (en) Composition and method for disease treatment
IL139235D0 (en) Pharmaceutical preparations
AU4606096A (en) Formulations and methods for reducing skin irritation
IL146119A (en) Medicament compositions based on anticholinergically effective compounds and beta-mimetics
AU5230399A (en) Pharmaceutical compositions and methods for managing scalp conditions
IL119864A (en) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol compounds, as pharmaceutically active compounds and their preparation
IL140353D0 (en) Pharmaceutical formulations for aerosols with two or more active substances
PL351526A1 (en) Pharmaceutical formulation comprising amoxycillin
EP0820277A4 (en) Powdered pharmaceutical formulations having improved dispersibility

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase